⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TEM News
Tempus AI, Inc. Class A Common Stock
Personalis Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Personalis, Inc. - PSNL
businesswire.com
TEM
PSNL
Form 8-K
sec.gov
TEM
PERSONALIS SHAREHOLDER ALERT: PSNL Shareholders Interested in Pursuing Potential Claims Should Contact Julie & Holleman Regarding Proposed Sale to Tempus
globenewswire.com
PSNL
TEM
Form 8-K
sec.gov
PSNL
TEM
Form 8-K
sec.gov
TEM
Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform
businesswire.com
TEM
PSNL
As AI Models Become Commodities, One Bio-Native AI Company Just Moved to Patent the Thing That Actually Compounds: the Data
prnewswire.com
ABCL
HYFT
SDGR
RXRX
TEM
Tempus Announces Research Collaboration with Angiosarcoma Awareness, Inc. to Uncover Insights on Rare Cancers
businesswire.com
TEM
16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap
prnewswire.com
HTFL
IRTC
TEM
BFLY
Genetics in Medicine Open Study Demonstrates How Ambry Genetics’ ExomeReveal® RNA Testing Can Improve Diagnostic Clarity in Exome Testing
businesswire.com
TEM